<DOC>
	<DOCNO>NCT00333112</DOCNO>
	<brief_summary>A study evaluate solifenacin succinate combination tamsulosin treatment residual OAB symptom men .</brief_summary>
	<brief_title>A Study Evaluate Solifenacin Succinate Combination With Tamsulosin Treatment Residual Overactive Bladder Symptoms ( OAB ) Men .</brief_title>
	<detailed_description>A 2 arm study ( 1 Active , 1 Placebo ) evaluate solifenacin succinate combination tamsulosin treatment residual OAB symptom men</detailed_description>
	<mesh_term>Urinary Incontinence</mesh_term>
	<mesh_term>Enuresis</mesh_term>
	<mesh_term>Tamsulosin</mesh_term>
	<mesh_term>Solifenacin Succinate</mesh_term>
	<criteria>Symptoms Overactive Bladder ( OAB ) Current use antimuscarinic therapy Evidence urinary tract infection</criteria>
	<gender>Male</gender>
	<minimum_age>45 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2014</verification_date>
	<keyword>Treatment Outcome</keyword>
	<keyword>Urology</keyword>
	<keyword>Solifenacin succinate</keyword>
	<keyword>Urinary Incontinence</keyword>
</DOC>